Spermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production
Oncogene · 18.02.2025 · 44 (5) · 296-306
DOI: 10.1038/s41388-024-03218-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncogene, online erschienen am 10.11.2024. Verfasst von Kara M McNamara und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Hauptthemen laut MEDLINE: Oxidoreductases Acting on CH-NH Group Donors, Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense (United States Department of Defense), NIDDK NIH HHS, U.S. Department of Veterans Affairs (Department of Veterans Affairs).
Abstract (Originalsprache)
Helicobacter pylori is the primary cause of gastric cancer, and there is a need to discover new molecular targets for therapeutic intervention in H. pylori disease progression. We have previously shown that spermine oxidase (SMOX), the enzyme that catabolizes the back-conversion of the polyamine spermine to spermidine, is upregulated during infection and is associated with increased cancer risk in humans. We sought to determine the direct role of SMOX in gastric carcinogenesis during H. pylori infection. In this study, we demonstrate that transgenic FVB/N insulin-gastrin (INS-GAS) mice that develop gastric carcinoma with H. pylori infection were protected from cancer development with Smox deletion. RNA sequencing revealed that genes associated with the immune system and cancer were downregulated in the infected Smox –/– mice. Furthermore, there was a decrease in cell proliferation and DNA damage in infected Smox –/– animals. There was significant generation of adducts of the highly reactive electrophile acrolein, a byproduct of SMOX activity, in gastric tissues from H. pylori -infected humans and wild-type, but not Smox –/– mice. Genetic deletion of Smox in murine organoids or chemical inhibition of SMOX in human gastric epithelial cells significantly reduced generation of acrolein induced by H. pylori . Additionally, acrolein-induced DNA damage in gastric epithelial cells was ablated with the electrophile scavenger 2-hydroxybenzylamine (2-HOBA). Gastric acrolein adduct levels were attenuated in infected INS-GAS mice treated with 2-HOBA, which exhibit reduced gastric carcinoma. These findings implicate SMOX and acrolein in H. pylori -induced carcinogenesis, thus indicating their potential as therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
- Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
- Center for Mucosal Inflammation and Cancer, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
- Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Franklin, TN, 37067, USA.
- Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
ORCID-Profile: Daniel P Barry, Margaret M Allaman, Yash A Choksi, Lori A Coburn, Alain P Gobert, Keith T Wilson
Förderung
- U.S. Department of Defense (United States Department of Defense)
- NIDDK NIH HHS
- U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive…
- CSRD VA
- BLRD VA
- NCI NIH HHS
Zitieren
APA
McNamara, K. M., Sierra, J. C., Latour, Y. L., Hawkins, C. V., Asim, M., Williams, K. J., Barry, D. P., Allaman, M. M., Zagol-Ikapitte, I., Luis, P. B., Schneider, C., Delgado, A. G., Piazuelo, M. B., Tyree, R. N., Carson, K. S., Choksi, Y. A., Coburn, L. A., Gobert, A. P., & Wilson, K. T. (2025). Spermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production. Oncogene, 44(5), 296-306. https://doi.org/10.1038/s41388-024-03218-7
Vancouver
McNamara KM, Sierra JC, Latour YL, Hawkins CV, Asim M, Williams KJ, et al. Spermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production. Oncogene. 2025;44(5):296-306. doi:10.1038/s41388-024-03218-7
BibTeX
@article{McNamara2025,
author = {McNamara, Kara M and Sierra, Johanna C and Latour, Yvonne L and Hawkins, Caroline V and Asim, Mohammad and Williams, Kamery J and Barry, Daniel P and Allaman, Margaret M and Zagol-Ikapitte, Irene and Luis, Paula B and Schneider, Claus and Delgado, Alberto G and Piazuelo, M Blanca and Tyree, Regina N and Carson, Kate S and Choksi, Yash A and Coburn, Lori A and Gobert, Alain P and Wilson, Keith T},
title = {Spermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production},
journal = {Oncogene},
year = {2025},
volume = {44},
number = {5},
pages = {296--306},
doi = {10.1038/s41388-024-03218-7}
}
EUVIMED